Safety of Herpes Zoster Vaccine in Lupus
Phase 4
224
about 3.6 years
18–90
2 sites in NY, OK
What this study is about
Researchers are testing the safety of a herpes zoster vaccine in people with lupus. The trial will evaluate whether this vaccine is safe and how well it works in individuals with varying levels of lupus activity, different ages, and exposure to immunosuppressant medications. Participants will receive either the vaccine or a placebo.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Herpes Zoster Subunit (HZ/su) Vaccine
- 2.Receive Placebo
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
vaccine
injection
Secondary: Occurrence of Grade 3 or Higher Adverse Events as Per CTCAE or Solicited AIT within 24 Weeks of First Dosing with HZ/su Vaccine
Immune